ResApp Health, Massachusetts General Hospital expand research partnership

Brisbane, Australia-based ResApp Health entered into a two-year expanded research collaboration with Massachusetts General Hospital in Boston. ResApp is a developer of smartphone medical applications for the diagnosis and management of respiratory diseases.

Advertisement

The hospital is participating in ResApp’s SMARTCOUGH-C study, which is examining the efficacy of the company’s cough-based diagnostic test. As per the expanded collaboration, the hospital and ResApp will perform additional analysis of the SMARTCOUGH-C study data and will use the dataset to examine the state of respiratory disease clinical practice today.

Peter Moschovis, MD, will lead the team at MGH.

More articles on health IT:
Study: Video games may improve mood, function in late life depression patients
Illumina taps IBM Watson for cancer data interpretation
Survey: 49% of health IT professionals worry about inappropriate employee use of mobile devices

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.